Antifungals and psilocybin.
7 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as antifungal
01 What the evidence covers
Best evidence available per medication| 7 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZVaginal yeast infection (vaginal candidiasis); Mouth, throat and esophageal yeast infections (candidiasis)
It may slow how the body clears psilocybin, raising levels. Also, it can cause heart-rhythm (QT) effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Blastomycosis; Histoplasmosis
It may slow how the body clears psilocybin by blocking a minor clearing enzyme. Also, its label warns of heart failure and heart-rhythm (QT) effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Serious fungal infections (blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, paracoccidioidomycosis) when other treatments fail; Ringworm, jock itch, and athlete's foot (tinea)
As tablets, it may slow how the body clears psilocybin; creams are barely absorbed. Also, tablets can cause liver injury and heart-rhythm (QT) effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not been curative
It may slow how the body clears psilocybin (not studied with psilocybin). Also, it can cause liver injury, heart-rhythm (QT) effects and low cortisol.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Invasive aspergillosis (treatment); Prevention of invasive Aspergillus and Candida infections in severely immunocompromised people
Not studied with psilocybin; it slows an enzyme that helps break down psilocybin, so higher levels are possible. Also, it can cause heart-rhythm (QT) effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Fungal nail infection (onychomycosis)
It strongly blocks one enzyme that breaks down psilocybin; gene differences in that enzyme did not change levels in people.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Invasive aspergillosis; Candidemia and deep tissue Candida infections
Not studied with psilocybin; it blocks an enzyme that clears psilocybin, so higher levels are possible. Also, it can affect heart rhythm and cause hallucinations.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 7 | Liver injury |
| 6 | QT-prolonging |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRecords reviewed 2026-10-03 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z